Effect of Cinnamic Acid and FOLFOX in Diminishing Side Population and Downregulating Cancer Stem Cell Markers in Colon Cancer Cell Line HT-29

Overview

Journal Daru

Specialty Pharmacology

Date 2018 Sep 14

PMID 30209760

Citations 11

Authors

Sara Soltanian

Helia Riahirad

Athareh Pabarja

Elham Jafari

Behjat Kalantari Khandani

Affiliations

Soon will be listed here.

Abstract

Purpose: There is a lot of evidence suggesting that a small subset of cancer cells resistant to conventional chemotherapy and radiotherapy and known as cancer stem cells (CSCs) is responsible for promoting metastasis and cancer relapse. Therefore, targeting and eliminating the CSCs could lead to higher survival rates and a better quality of life. In comparison with conventional chemical drugs that may not be effective against CSCs, phytochemicals are strong anti-CSCs agents. The current study examines the effect of 5-fluorouracil plus oxaliplatin (FOLFOX) as a common chemotherapy drug on colorectal cancer as well as the influence of Cinnamic acid (CINN) as a plant-derived phytochemical on colon cancer stem-like cells in HT-29 adenocarcinoma cell line.

Methods: The anti-proliferative effect of FOLFOX and CINN was determined using MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay. Flow cytometry analysis was used for the identification of side population (SP), CD44, and CD133 positive cells. The expression of OCT4, NANOG, ABCB1, and ALDH1A was assessed by RT-PCR.

Results: The FOLFOX and CINN decreased cell viability in certain drug concentrations: IC50 = 5,40 μM oxaliplatin +220 μM 5-fluorouracil, and 13,50 mM for CINN. The CSC-associated markers (OCT4, NANOG, ABCB1, and ALDH1A) and the proportion of cancer stem-like cells (SP cells, CD44, and CD133 positive cells) were downregulated following the treatment of HT-29 adenocarcinoma cell line with IC50 concentrations of FOLFOX and CINN.

Conclusion: Our data suggests that CINN, a naturally occurring component, could be more effective than FOLFOX treatment in reducing the cancer stem-like cells and expression of CSC markers from HT-29 colon cancer cells. Graphical abstract ᅟ.

Citing Articles

Molecular Mechanisms of Dietary Compounds in Cancer Stem Cells from Solid Tumors: Insights into Colorectal, Breast, and Prostate Cancer.

Filippi A, Deculescu-Ionita T, Hudita A, Baldasici O, Galateanu B, Mocanu M Int J Mol Sci. 2025; 26(2).

PMID: 39859345 PMC: 11766403. DOI: 10.3390/ijms26020631.

Targeting Cervical Cancer Stem Cells by Phytochemicals.

Tripathi T, Yadav J, Janjua D, Chaudhary A, Joshi U, Senrung A Curr Med Chem. 2024; 31(32):5222-5254.

PMID: 38288813 DOI: 10.2174/0109298673281823231222065616.

Bioactive Compounds of Dietary Origin and Their Influence on Colorectal Cancer as Chemoprevention.

Delgado-Gonzalez P, Garza-Trevino E, de la Garza Kalife D, Quiroz Reyes A, Hernandez-Tobias E Life (Basel). 2023; 13(10).

PMID: 37895359 PMC: 10608661. DOI: 10.3390/life13101977.

The Determination of Cisplatin and Luteolin Synergistic Effect on Colorectal Cancer Cell Apoptosis and Mitochondrial Dysfunction by Fluorescence Labelling.

Ozerkan D J Fluoresc. 2023; 33(3):1217-1225.

PMID: 36652047 DOI: 10.1007/s10895-023-03145-y.

Cinnamomi Ramulus inhibits the growth of colon cancer cells via Akt/ERK signaling pathways.

Pan B, Xia Y, Gao Z, Zhao G, Wang L, Fang S Chin Med. 2022; 17(1):36.

PMID: 35264225 PMC: 8905814. DOI: 10.1186/s13020-022-00588-6.

References

Wang J, Dick J . Cancer stem cells: lessons from leukemia. Trends Cell Biol. 2005; 15(9):494-501. DOI: 10.1016/j.tcb.2005.07.004. View

Lin M, Liu L, Li C, Zhang M, Chen Y, Qin J . Scutellaria extract decreases the proportion of side population cells in a myeloma cell line by down-regulating the expression of ABCG2 protein. Asian Pac J Cancer Prev. 2014; 14(12):7179-86. DOI: 10.7314/apjcp.2013.14.12.7179. View

Xiong B, Ma L, Hu X, Zhang C, Cheng Y . Characterization of side population cells isolated from the colon cancer cell line SW480. Int J Oncol. 2014; 45(3):1175-83. DOI: 10.3892/ijo.2014.2498. View

Li C, Heidt D, Dalerba P, Burant C, Zhang L, Adsay V . Identification of pancreatic cancer stem cells. Cancer Res. 2007; 67(3):1030-7. DOI: 10.1158/0008-5472.CAN-06-2030. View

Patel B, Gupta D, Elliott A, Sengupta V, Yu Y, Majumdar A . Curcumin targets FOLFOX-surviving colon cancer cells via inhibition of EGFRs and IGF-1R. Anticancer Res. 2010; 30(2):319-25. PMC: 3836443. View

Dalerba P, Dylla S, Park I, Liu R, Wang X, Cho R . Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci U S A. 2007; 104(24):10158-63. PMC: 1891215. DOI: 10.1073/pnas.0703478104. View

Torquato H, Goettert M, Justo G, Paredes-Gamero E . Anti-Cancer Phytometabolites Targeting Cancer Stem Cells. Curr Genomics. 2017; 18(2):156-174. PMC: 5345336. DOI: 10.2174/1389202917666160803162309. View

De P, Baltas M, Bedos-Belval F . Cinnamic acid derivatives as anticancer agents-a review. Curr Med Chem. 2011; 18(11):1672-703. DOI: 10.2174/092986711795471347. View

de Oliveira Niero E, Machado-Santelli G . Cinnamic acid induces apoptotic cell death and cytoskeleton disruption in human melanoma cells. J Exp Clin Cancer Res. 2013; 32:31. PMC: 3667113. DOI: 10.1186/1756-9966-32-31. View

10.

Park S, Sung J, Han S, Baek J, Oh J, Bang S . Oxaliplatin, folinic acid and 5-fluorouracil (FOLFOX-4) combination chemotherapy as second-line treatment in advanced colorectal cancer patients with irinotecan failure: a Korean single-center experience. Jpn J Clin Oncol. 2005; 35(9):531-5. DOI: 10.1093/jjco/hyi140. View

11.

Lee S, Han J, Kim H, Kim E, Jeong T, Lee W . Synthesis of cinnamic acid derivatives and their inhibitory effects on LDL-oxidation, acyl-CoA:cholesterol acyltransferase-1 and -2 activity, and decrease of HDL-particle size. Bioorg Med Chem Lett. 2004; 14(18):4677-81. DOI: 10.1016/j.bmcl.2004.06.101. View

12.

Kallifatidis G, Rausch V, Baumann B, Apel A, Beckermann B, Groth A . Sulforaphane targets pancreatic tumour-initiating cells by NF-kappaB-induced antiapoptotic signalling. Gut. 2008; 58(7):949-63. DOI: 10.1136/gut.2008.149039. View

13.

Erdogan S, Doganlar O, Doganlar Z, Serttas R, Turkekul K, Dibirdik I . The flavonoid apigenin reduces prostate cancer CD44(+) stem cell survival and migration through PI3K/Akt/NF-κB signaling. Life Sci. 2016; 162:77-86. DOI: 10.1016/j.lfs.2016.08.019. View

14.

Webb M, Raphael C, Asbahr H, Erber W, Meyer B . The detection of rhodamine 123 efflux at low levels of drug resistance. Br J Haematol. 1996; 93(3):650-5. DOI: 10.1046/j.1365-2141.1996.d01-1680.x. View

15.

Shankar S, Singh G, Srivastava R . Chemoprevention by resveratrol: molecular mechanisms and therapeutic potential. Front Biosci. 2007; 12:4839-54. DOI: 10.2741/2432. View

16.

Moharil R, Dive A, Khandekar S, Bodhade A . Cancer stem cells: An insight. J Oral Maxillofac Pathol. 2018; 21(3):463. PMC: 5763886. DOI: 10.4103/jomfp.JOMFP_132_16. View

17.

Shudo N, Mizoguchi T, Kiyosue T, Arita M, Yoshimura A, Seto K . Two pyridine analogues with more effective ability to reverse multidrug resistance and with lower calcium channel blocking activity than their dihydropyridine counterparts. Cancer Res. 1990; 50(10):3055-61. View

18.

Jiang F, Qiu Q, Khanna A, Todd N, Deepak J, Xing L . Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer. Mol Cancer Res. 2009; 7(3):330-8. PMC: 4255559. DOI: 10.1158/1541-7786.MCR-08-0393. View

19.

Kim J, Ko E, Han W, Shin I, Park S, Noh D . Berberine diminishes the side population and ABCG2 transporter expression in MCF-7 breast cancer cells. Planta Med. 2008; 74(14):1693-700. DOI: 10.1055/s-0028-1088313. View

20.

Dantzig A, Shepard R, Pratt S, Tabas L, Lander P, Ma L . Evaluation of the binding of the tricyclic isoxazole photoaffinity label LY475776 to multidrug resistance associated protein 1 (MRP1) orthologs and several ATP- binding cassette (ABC) drug transporters. Biochem Pharmacol. 2004; 67(6):1111-21. DOI: 10.1016/j.bcp.2003.11.006. View